Chronic Pelvic Pain Syndrome: Reduction of Medication Use After Pelvic Floor Physical Therapy with an Internal Myofascial Trigger Point Wand

详细信息    查看全文

• 作者：Rodney U. Anderson ; Richard H. Harvey…
• 关键词：Myofascial trigger point release ; Chronic pelvic pain syndrome ; Paradoxical relaxation ; Physical therapy
• 刊名：Applied Psychophysiology and Biofeedback
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：40
• 期：1
• 页码：45-52
• 全文大小：563 KB
• 参考文献：1. Anderson, RU, Nathanson, BH (2011) Pain: Drug therapies for CP/CPPS: Help or hype?. Nature Reviews Urology 8: pp. 236-237 CrossRef
  2. Anderson, RU, Wise, D, Sawyer, T, Chan, C (2005) Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. The Journal of Urology 174: pp. 155-160 CrossRef
  3. Anderson, RU, Wise, D, Sawyer, T, Glowe, P, Orenberg, EK (2011) 6-Day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. The Journal of Urology 185: pp. 1294-1299 CrossRef
  4. Anderson, R, Wise, D, Sawyer, T, Nathanson, BH (2011) Safety and effectiveness of an internal pelvic myofascial trigger point wand for urologic chronic pelvic pain syndrome. The Clinical Journal of Pain 27: pp. 764-768 CrossRef
  5. Anothaisintawee, T, Attia, J, Nickel, JC, Thammakraisorn, S, Numthavaj, P, McEvoy, M, Thakkinstian, A (2011) Management of chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis. JAMA 305: pp. 78-86 CrossRef
  6. Calhoun, EA (2004) The economic impact of chronic prostatitis. Archives of Internal Medicine 164: pp. 1231 CrossRef
  7. Clemens, JQ, Markossian, T, Calhoun, EA (2009) Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome. Urology 73: pp. 743-746 CrossRef
  8. Cornel, EB, Haarst, EP, Schaarsberg, RW, Geels, J (2005) The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. European Urology 47: pp. 607-611 CrossRef
  9. Dellit, TH, Owens, RC, McGowan, JE, Gerding, DN, Weinstein, RA, Burke, JP, Hooton, TM (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases 44: pp. 159-177 CrossRef
  10. Duclos, AJ, Lee, CT, Shoskes, DA (2007) Current treatment options in the management of chronic prostatitis. Therapeutics and Clinical Risk Management 3: pp. 507
  11. FitzGerald, MP, Anderson, RU, Potts, J, Payne, CK, Peters, KM, Clemens, JQ, Nyberg, LM (2009) Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. The Journal of Urology 182: pp. 570-580 CrossRef
  12. FitzGerald, MP, Payne, CK, Lukacz, ES, Yang, CC, Peters, KM, Chai, TC, Nyberg, LM (2012) Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. The Journal of Urology 187: pp. 2113-2118 CrossRef
  13. Habermacher, GM, Chason, JT, Schaeffer, AJ (2006) Prostatitis/chronic pelvic pain syndrome. Annual Review of Medicine 57: pp. 195-206 CrossRef
  14. Hanno, PM, Burks, DA, Clemens, JQ, Dmochowski, RR, Erickson, D, FitzGerald, MP, Faraday, MM (2011) AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. The Journal of Urology 185: pp. 2162-2170 CrossRef
  15. Khorasani, B, Arab, AM, Sedighi Gilani, MA, Samadi, V, Assadi, H (2012) Transabdominal ultrasound measurement of pelvic floor muscle mobility in men with and without chronic prostatitis/chr
• 刊物类别：Behavioral Science
• 刊物主题：Psychology
  Psychology
  Health Psychology
  Stress and Coping
  Public Health
  
• 出版者：Springer Netherlands
• ISSN：1573-3270

文摘

This study documents the voluntary reduction in medication use in patients with refractory chronic pelvic pain syndrome utilizing a protocol of pelvic floor myofascial trigger point release with an FDA approved internal trigger point wand and paradoxical relaxation therapy. Self-referred patients were enrolled in a 6-day training clinic from October, 2008 to May, 2011 and followed the protocol for 6?months. Medication usage and symptom scores on a 1-0 scale (10?=?most severe) were collected at baseline, and 1 and 6?months. All changes in medication use were at the patient’s discretion. Changes in medication use were assessed by McNemar’s test in both complete case and modified intention to treat (mITT) analyses. 374 out of 396 patients met inclusion criteria; 79.7?% were male, median age of 43?years and median symptom duration of 5?years. In the complete case analysis, the percent of patients using medications at baseline was 63.6?%. After 6?months of treatment the percentage was 40.1?%, a 36.9?% reduction (p?p?p?=?0.03).